| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
96,000
|
— | ₹0.35 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 1,848,000 |
100% | ₹6.65 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 96,000 | ₹0.35 |
5.19%
|
| Total | 1,848,000 | ₹6.65 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 6,000 | ₹216,000 |
| Retail (Max — 13 Lots) | 13 | 39,000 | ₹1,404,000 |
| S-HNI (Min — 14 Lots) | 14 | 42,000 | ₹1,512,000 |
| B-HNI (Min — 68 Lots) | 68 | 204,000 | ₹7,344,000 |
| Particulars | 31-Dec-18 | 31-Mar-18 | 31-Dec-17 |
|---|---|---|---|
| Revenue from Operations | 3449.85 | 3543.67 | 2333.95 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 86.51 | 85.65 | 15.98 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 2741.00 | 2052.88 | 1108.45 |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Earum Pharmaceuticals Ltd. IPO is subscribed 1.00 times by Jun 26, 2019. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Earum Pharmaceuticals Ltd. IPO retail category is subscribed 1.00 times as of 26 Jun 2019. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 21 Jun 2019 and closes 26 Jun 2019. Min investment: ₹108,000 (1 lot = 3,000 shares). UPI mandate: 2019-06-26.
The Earum Pharmaceuticals Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (Bigshare Services Pvt.Ltd.) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 01 Jul 2019. Refunds: on 02 Jul 2019.
The Earum Pharmaceuticals Ltd. IPO listing date is 04 Jul 2019, Thursday. Listed on: BSE SME. Issue price: ₹36. Estimated listing: ₹36. GMP: NIL.
The Earum Pharmaceuticals Ltd. IPO closes on 26 Jun 2019, Wednesday. UPI mandate: 2019-06-26. Allotment: 01 Jul 2019. Listing: 04 Jul 2019.